Effect of ampicillin versus cefuroxime on the emergence of β-lactam resistance in faecal enterobacter cloacae isolates from neonates

Journal of Antimicrobial Chemotherapy

Volumn 31, Issue 1, 1993, Pages 111-116

  Burman, L G ^a   Berglund, B ^a   Huovinen, P ^b   Tullus, K ^c  

^a National Bacteriological Laboratory   (Sweden)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALEXIN; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; PIPERACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; BACTERIUM MUTANT; CONTROLLED STUDY; DNA HYBRIDIZATION; DRUG EFFECT; ENTEROBACTER CLOACAE; FECES MICROFLORA; HUMAN; INFANT; ISOELECTRIC FOCUSING; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NONHUMAN; PLASMID; PRIORITY JOURNAL;

AMPICILLIN; ANTIBIOTICS, LACTAM; BACTERIAL TYPING TECHNIQUES; CEFUROXIME; COMPARATIVE STUDY; DRUG RESISTANCE, MICROBIAL; ENTEROBACTER CLOACAE; FECES; HUMAN; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; SUPPORT, NON-U.S. GOV'T; SWEDEN;

EID: 0027462546     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/31.1.111     Document Type: Article

References (24)

1. Bryan, C. S., John, J. F., Pai, M. S. & Austin, T. L. (1985). Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance. American Journal of Diseases of Children 139, 1086-9.
2. Centers for Disease Control. (1984). Nosocomial infection surveillance, 1983. Morbidity and Mortality Weekly Report. CDC Surveillance Summaries 33, 9SS-21SS.
3. Centers for Disease Control. (1986). Nosocomial infection surveillance, 1984. Morbidity and Mortality Weekly Report. CDC Surveillance Summaries 35, Suppl. 1SS, 17SS-29SS.
4. Gallagher, P. G. (1990). Enterobacter bacteremia in pediatrie patients. Reviews of Infectious Diseases 12, 808-12.
5. Gaston, M. A. (1988). Enterobacter- an emerging nosocomial pathogen. Journal of Hospital Infection 11, 197-208.
6. Huovinen, S., Huovinen, P. & Jacoby, G. A. (1988). Detection of plasmid-mediated β-lactamases with DNA probes. Antimicrobial Agents and Chemotherapy 32, 175-9.
7. John, J. F., Sharbaugh, R. J. & Bannister, E. R. (1982). Enterobacter cloacae: bacteremia, epidemiology, and antibiotic resistance. Reviews of Infectious Diseases 4, 13-28.
8. Kühn, I., Tullus, K. & Burman, L. G. (1991). Epidemiological studies of fecal Enterobacter cloacae from infants in Swedish neonatal wards using biochemical fingerprinting with the PhP-KE system. Journal of Microbiological Methods, in press.
9. Lindh, E., Dornbusch, K., Jalakas, K. & Forsgren, A. (1990). Antibiotic susceptibility and β-lactamase production in clinical isolates of Enterobacter spp. AMPMIS 98, 462-70.
10. Livermore, D. M. (1987). Clinical significance of /Mactamase induction and stable derepression in Gram-negative rods. European Journal of Clinical Microbiology 6, 439-45.
11. McCracken, G. H., Nelson, J. D., Kaplan, S. L., Overturf, G. D., Rodriguez, W. J. & Steele, R. W. (1987). Consensus report: antimicrobial therapy for bacterial meningitis in infants and children. Pediatrie Infectious Disease Journal 6, 501-5.
12. Michéa-Hamzehpour, M. & Pechère, J. C. (1989). How predictable is development of resistance after β-lactam therapy in Enterobacter cloacae infection? Journal of Antimicrobial Chemotherapy 24, 387-95.
13. Modi, N., Damjanovic, V. & Cooke, R. W. I. (1987). Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit. Archives of Disease in Childhood 62, 148-51.
14. Nauciel, C, Philippon, A., Ronco, E., Pilliot, J., Guenounou, M., Paul, G. et al. (1985). Septicémies à Enterobacter cloacae et E. aerogenes: émergence de variants résistants (céphalosporinase déréprimée) en cours de traitement par des céphalosporines de troisième génération. Presse Médicale 14, 673-6.
15. Nicolle, L. E. (1988). Prior antimicrobial therapy and resistance of Enterobacter, Citrobacter and Serratia to third generation cephalosporins. Journal of Hospital Infection 11, 321-7.
16. Quinn, J. P., DiVencenzo, C. A. & Foster, J. (1987). Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections. Journal of Infectious Diseases 155, 942-7.
17. Ralph, E. D. & Behme, R. J. (1987). Enterobacter meningitis-treatment complicated by emergence of mutants resistant to cefotaxime. Scandinavian Journal of Infectious Diseases 19, 577-9.
18. Ristuccia, P. A. & Cunha, B. A. (1985). Enterobacter. Infection Controle, 124-8.
19. Sanders, C. C. & Sanders, W. E. (1986). Type I β-lactamases of Gram-negative bacteria: interactions with β-lactam antibiotics. Journal of Infectious Diseases 154, 792-800.
20. Sanders, C. C. & Sanders, W. E. (1987). Clinical importance of inducible β-lactamases in Gram-negative bacteria. European Journal of Clinical Microbiology 4, 435-8.
21. Spritzer, R., Kamp, H. J. V. D., Dzoljic, G. & Sauer, P. J. J. (1990). Five years of cefotaxime use in a neonatal intensive care unit. Pediatrie Infectious Disease Journal 9, 92-6.
22. Tullus, K., Fryklund, B., Berglund, B., Källenius, G. & Burman, L. G. (1988). Influence of age on faecal carriage of P-fimbriated Escherichia coli and other Gram-negative bacteria in hospitalized neonates. Journal of Hospital Infection 11, 349-56.
23. Tullus, K., Olsson-Liljequist, B., Lundström, G. & Burman, L. G. (1991). Antibiotic susceptibility of 629 bacterial blood and CSF isolates from Swedish infants and the therapeutic implications. Ada Paediatrica Scandinavica 80, 205-12.
24. Weinstein, R. A. (1986). Endemic emergence of cephalosporin-resistant Enterobacter relation to prior therapy. Infection Control 7, Suppl. 2, 120-3.